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Abstract
Sick neonates are often hemodynamically unstable, hence their organs are inadequately 
supplied with oxygen. In order to maintain blood flow to vital organs, a number of 
compensatory mechanisms divert the blood flow away from the non‐vital organs. If 
hemodynamic changes are detected early, the cardiovascular compromise can be rec‐
ognized in compensated phase and thereby the escalation to decompensated phase of 
low cardiac output syndrome might be prevented. In the treatment of hemodynamically 
unstable neonate venous filling, contractility of the heart muscle, blood pressure in the 
aorta, systemic blood flow, and regional distribution of blood flow should be evalu‐
ated. There are many evaluation and measurement methods based on different physical 
basis, each of them having their advantages and disadvantages. For most of them, it 
has not been demonstrated that they improve outcomes of sick neonates. Using these 
methods, useful hemodynamic data for the treatment of sick neonates can be obtained. 
Using new techniques will clarify the pathophysiology of cardiovascular failure in sick 
neonates, assess the effects of drugs on blood pressure and perfusion of the heart and 
other organs.
Keywords: neonate, hemodynamics, oxygenation, perfusion, arterial blood pressure, 
cardiac output, peripheral vascular resistance
1. Introduction
In neonatal intensive care unit (NICU), hemodynamic instability is an important cause for admis‐
sion and treatment after respiratory distress syndrome (RDS) and most common problems of 
prematurity [1]. Therefore, hemodynamic monitoring is important especially in transitional 
period to extrauterine life and during the next following days. Hemodynamic monitoring is 
also crucial in neonates with congenital heart defects (CHDs) and other complex surgical anom‐
alies of neonates. During early transitional period, cardiac output (CO) is not dependent solely 
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on the performance of the neonate’s left ventricle but also on pulsating blood flow through the 
umbilical vein. This pulsating blood flow is extremely important especially if newborn is under 
fetal distress, and it is usually prudent to postpone ligation of umbilicus for a short period of 
time to add additional pulsatile and volume support to neonate’s CO [2, 3]. Even later in the 
life, neonate with RDS requires hemodynamic monitoring due to disturbances related to RDS 
or other common problems of prematurity or immaturity. Besides prematurity, immaturity of 
cardiovascular system in the first days and weeks of life and altered physiology of systemic and 
pulmonary circulation in neonates with CHD may need frequent hemodynamic monitoring, 
whether invasively or noninvasively.
2. Methods
We conducted electronic searches of articles on hemodynamic management and care of 
neonates, using key terms: neonate, hemodynamics, oxygenation, perfusion, arterial blood 
pressure, cardiac output, and peripheral vascular resistance in the PubMed data base from 
the years 2000 to 2017 and reported the most relevant ones. The article lists the methods 
for the evaluation of the venous filling, cardiac output, blood pressure, regional blood flow, 
and microcirculation, from the clinical methods to the noninvasive and invasive ones. Some 
methods for monitoring the cardiovascular status of neonates are mainly used for research 
purposes. This chapter includes the impact of optimal arterial blood pressure, tissue perfu‐
sion, and persistent ductus arteriosus on the hemodynamic management in neonates. Also, 
the short‐ and long‐term outcomes in respect of hemodynamic management of neonates in 
the intensive care unit are addressed.
3. Physiology of hemodynamics
Hemodynamics describes the dynamics of blood flow in the body. Blood flows in the cir‐
culatory system, which is composed of the central pump—the heart—and the blood ves‐
sels, and is controlled by homeostatic mechanisms. The pulsatile rate of blood flow out 
of the heart is called the cardiac output. The main role of the cardio‐circulatory system is 
to match the oxygen and nutrient needs of the organs and tissues and elimination of the 
metabolic wastes. The cardio‐circulatory system should provide an appropriate blood flow 
to the organs and by that an appropriate tissue perfusion. In the physiologic conditions, 
the tissue oxygen and nutrient needs are matched by their supply. In cardiovascular com‐
promise, the compensatory mechanisms allow the redistribution of blood flow to the vital 
organs—the brain, heart, and suprarenal gland in the neonate—at the expense of decreased 
blood flow to the non‐vital organs.
3.1. Hemodynamic monitoring
Hemodynamic monitoring encompasses the observation and measurement of hemody‐
namic parameters over time. The ultimate goals of hemodynamic monitoring is to alert the 
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health‐care team of impending cardiovascular crisis, to obtain information specific to the dis‐
ease processes, which may facilitate diagnosis and treatment and allow one to monitor the 
response to therapy, and also to derive estimates of performances and physiological reserve 
that may in turn direct treatment [4]. The purpose of hemodynamic monitoring is to attain 
the optimal goals of cardiovascular therapy. Three functional‐based questions should be 
addressed: (1) Will blood flow to the body increase (or decrease) if the neonates’ intravascu‐
lar volume is increased (or decreased), and if so, by how much? (2) Is the decrease in arterial 
blood pressure due to loss of vascular tone or merely due to inadequate blood flow? (3) Is the 
heart capable of maintaining an effective blood flow with an acceptable perfusion pressure 
without going into failure?
Physiologically, hemodynamic parameters can be divided into central or macro‐hemody‐
namic parameters, which assess blood flow and pressure in the heart, vena cava, pulmo‐
nary artery, and the aorta, and the peripheral or micro‐hemodynamic parameters, which 
assess the regional microvascular blood flow and tissue oxygenation (Table 1). The major‐
ity of existing hemodynamic monitoring assesses the central part of the cardio‐circulatory 
system.
In the past, hemodynamic monitoring data were attained in neonates with CHD after heart 
surgery when the invasive and frequently inaccurate pulmonary artery catheters have been 
inserted [5]. Recently, efforts have been made to monitor the newborns as noninvasively 
Hemodynamic 
parameter
Physiologic 
parameter
Clinical assessment Noninvasive 
measurement
Invasive 
measurement
Central or macro Preload—venous 
filling
Estimating jugular 
venous pressure, hand 
pressure on the liver, 
elevation of the legs
Inferior vena cava 
diameter and its 
collapsibility, lung 
ultrasonography
Central venous 
catheters*
Cardiac output Palpating peripheral 
pulses, heart rate*, 
capillary refill time, 
peripheral‐core 
temperature difference
Echocardiography, 
cardiac magnetic 
resonance, electrical 
cardiometry*, 
arterial pulse 
waveform analysis*, 
electrocardiogram
Arterial catheters*
Afterload—arterial 
blood pressure
Palpating peripheral 
pulses
Cuff oscillometry, 
Doppler ultrasound
Arterial catheters*
Peripheral or micro Regional blood flow Skin color, lactate Perfusion index*, near‐
infrared spectroscopy*
Microcirculation Laser‐Doppler method, 
video microscopy, xenon 
clearance techniques
*Continuous method, all others are intermittent.
Table 1. Physiologic hemodynamic parameters in neonates, assessed clinically, noninvasively, and invasively.
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as possible and many new techniques have been applied in this vulnerable population 
to measure the central (arterial blood pressure and systemic blood flow) and peripheral 
hemodynamic parameters (peripheral vascular resistance). Arterial blood pressure is mea‐
sured either noninvasively by sphygmomanometer or invasively through arterial catheters. 
Systemic blood flow is noninvasively assessed by echocardiography, cardiac magnetic reso‐
nance, electrical cardiometry, and arterial pulse waveform analysis. Invasive methods for 
measuring the systemic blood flow are applied through centrally inserted vascular cath‐
eters. It is not known whether laser‐Doppler and spectroscopy in the near‐infrared spec‐
trum (near‐infrared spectroscopy, NIRS) can reliably monitor peripheral vascular resistance 
(Figure 1) [6].
Figure 1. Assessment of hemodynamic status in neonatal intensive care unit. Adapted from Ref. [64]. aEEG, amplitude‐
integrated electroencephalogram; BGA, blood gas analysis; ECG, electrocardiogram; NIRS, near‐infrared spectroscopy; 
PICCO, pulse‐induced contour cardiac output.
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4. The central hemodynamic monitoring
The central hemodynamic monitoring assesses the blood flow and the blood pressure in the 
heart and major vessels. The heart function and by that the stroke volume (SV) are determined 
by the preload—the venous filling, contractility of the heart muscle, and the afterload—which 
can be estimated only partially with the pressure in the aorta. The CO is the product of the SV 
and the heart rate (HR). Neonates increase their CO mainly by increasing the HR as they can‐
not sufficiently increase the SV. The HR is influenced by the body temperature, catecholamine 
secretion, and the autonomic nervous system.
4.1. The preload assessment
Clinically, the preload can be assessed visually assessing the jugular venous pressure, which 
is rarely possible in neonates with short neck. Using the hand pressure on the liver or eleva‐
tion of the legs increases preload and is a simple method of assessing preload but less used 
in the NICU. The venous filling in neonates can be measured by inferior vena cava (IVC) 
diameter, and its collapsibility during respiration indicates volume responsiveness [7, 8]. IVC 
assessment is not an accurate marker of volume status and fluid responsiveness in cases of 
(1) increased right atrial pressure, (2) tricuspid or pulmonary valve regurgitation, (3) pulmo‐
nary hypertension, or (4) right ventricular dysfunction. Another method for assessing volume 
status of a neonate is lung ultrasonography (US) [9, 10]. Sonographic visualization of B‐lines 
and measurement of extravascular lung water may aid diagnosing early volume overload 
in neonate. In a neonate with RDS after receiving surfactant, the B‐lines are still visible [11].
4.2. Cardiac output
The measurement of CO is the most important parameter of the central hemodynamic moni‐
toring, assessing the perfusion of organs. It is vital for the etiopathogenic diagnosis of low 
cardiac output syndrome, being due to either hypovolemia, myocardial dysfunction, vasodila‐
tation, tamponade, pneumothorax, obstructive shock, pulmonary hypertension, or acute RDS. 
CO should be measured in the following clinical conditions: congenital and acquired heart 
diseases, shock, multiple organ failure, cardiopulmonary interactions during mechanical ven‐
tilation, clinical research, and assessment of new therapies [12]. The following three questions 
guide us in the interpretation of the adequacy of CO: (1) Is the delivery of oxygen adequate 
to meet the metabolic need of the patient? (2) Is oxygen delivery occurring with an adequate 
perfusion pressure? (3) Is the patient able to utilize the oxygen delivered, and if not, why so? 
[13]. Not only the measurement but also adequacy of CO and oxygen delivery is important, 
reflecting in clinical (capillary refill and core‐peripheral temperature difference) and labora‐
tory (lactic acid) parameters. But caveat is needed; normal values do not mean that regional 
perfusion is adequate, as well as abnormal values do not provide us with etiologic clue.
Clinically, CO with the systemic blood flow and perfusion can indirectly noninvasively be 
assessed by palpating the peripheral pulses and heart rate, capillary refill time, and measuring 
the peripheral‐core temperature difference [14]. None of clinical methods for the evaluation 
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of CO is definitely reliable [15]. The HR in neonate is affected by many factors and so it is 
not necessarily a good indicator of hemodynamic status. In hypovolemic state, the immature 
heart muscle and the autonomic nervous system impact the cardiovascular response differ‐
ently in neonates in comparison to adults. The capillary refill time is affected by the pres‐
sure technique, variability among investigators, ambient temperature, drugs, and maturity of 
neonatal skin. The capillary refill time of >3 s has 55% sensitivity and 81% specificity for the 
prediction of the low systemic blood flow [16].
Noninvasive methods that are used in clinical practice to assess neonatal CO are echocar‐
diography, cardiac magnetic resonance, electrical cardiometry, and arterial pulse waveform 
analysis. Functional echocardiography (fECHO) enables visualization of the shape and size 
of the chambers of the heart, the heart valves, contractility, and relaxation of the heart muscle. 
Various forms of Doppler echocardiography, such as color, continuous and pulsed Doppler 
echocardiography, enable the determination of both the blood flow direction and velocity. By 
assessing the velocity of blood flow, two more parameters can be calculated: the difference 
in pressure above and below the narrowing with the modified Bernoulli’s equation and the 
blood flow through the blood vessel diameter and a mean flow velocity of the blood [17].
fECHO is daily used in the neonatal intensive medicine and constitutes an important part of 
an integrated bedside hemodynamic monitoring of a neonate. An appropriate training and 
experience is necessary for performing fECHO; so the obtained measurements are accurate 
and reliable. It should be noted that fECHO is not a substitute for formal echocardiographic 
assessment of the neonate by a pediatric cardiologist, especially if the newborn is suspected 
to have CHD or the latter has already been diagnosed [18, 19]. fECHO enables discontinuous 
hemodynamic assessment of neonate in real time. With fECHO, we can estimate the central 
venous pressure, and thus the volume of blood, and the contractility and filling of the right 
and left cavities, pulmonary arterial pressure, and the SV of the both ventricles, thereby CO. 
With neonatal fECHO, we can assess the presence, direction, and measure the blood flow 
velocity through the shunts, such as persistent ductus arteriosus (PDA) and open foramen 
ovale, the pressure in the pulmonary artery and the superior vena cava (SVC) and thereby 
assess heart function. The drawback is the limited accuracy of the measurements (10% with 
a single investigator and 20% among various investigators). Acquired measurements also 
depend on the blood flow: from the transitional to neonatal, shunts through connections 
between the pulmonary and systemic blood flow and immaturity or lability of the lung vas‐
culature, and thus the pressure in the pulmonary artery [20].
fECHO is helpful in the treatment of neonates with cardiovascular instability, PDA, persistent 
pulmonary hypertension, preterm premature rupture of membranes, perinatal asphyxia, sep‐
sis, and general management in intensive care for a sick neonate. In the case of hemodynami‐
cally significant PDA, fECHO has significant limitations in measuring CO. Significant left‐right 
shunting through PDA apparently increases SV of the left ventricle, which is a measure of pul‐
monary blood flow; outflow from the right ventricle is a measure of the systemic blood flow. 
Similarly, the measurement of flow from the right ventricle is affected by the presence of left‐
right atrial shunting which apparently increases SV and the outflow from the right ventricle. 
For this reason, the assessment of the systemic blood flow is made through the measurement 
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of the venous return to the heart through the SVC. The flow in the SVC is normally between 
30 and 50% of the total systemic blood flow. Similarly, to assess the pulmonary blood flow, the 
blood flow velocity in the left pulmonary artery is measured [21].
Measuring the ejection fraction (EF) and fractional shortening (FS) in hemodynamic monitor‐
ing of the newborn is not very useful measurement, except in the case of severe myocardial 
dysfunction, when measurements are not really necessary, since the poor contractility of the 
heart muscle is obvious. We calculate them on the basis of measurement differences in dimen‐
sions of left ventricle in the long axis between diastole and systole. The problem of measure‐
ment in neonates is that the anterior wall of the ventricle is relatively stiff in comparison to 
the posterior and lateral wall of the left ventricle. To avoid this, they proposed measuring the 
dimensions of the left ventricle in short axis [22]. Two new US methods for assessing cardiac 
function are the measurement of diastolic function and tissue Doppler US. Diminished dia‐
stolic relaxation effects systolic function of the heart muscle, and thus the SV and CO. We may 
assess the diastolic function from the shape of Doppler wave of the inflow of blood into the 
ventricle. The filling of the ventricle has two phases: early ventricular filling during relaxation 
(E wave) and late active ventricular filling due to atrial systole (A wave). In a healthy neo‐
nate, 80% of the blood fills the left ventricle early in diastole, so the predominance of A wave 
indicates impaired diastolic function [23]. But when assessing impaired diastolic function, we 
have to be aware that diastolic function in premature and mature infants is already impaired 
because of immature contractile system of cardiac muscles [22]. The method of tissue Doppler 
echocardiography detects low frequency of high energy resulting from the movement of the 
ventricular wall which cannot be assessed by the standard Doppler investigation. In the four‐
chamber view of the heart in the longitudinal axis, we observe three different variables of 
ventricular wall motion: velocity, acceleration, and displacement [24]. Even if the method is 
advantageously used in adult patients, their clinical utility in the treatment of sick newborns 
is not yet fully understood [25].
Cardiovascular magnetic resonance (CMR) imaging is a method of nuclear magnetic resonance 
based on the spinning of hydrogen nuclei in a magnetic field, which are most numerous in the 
human body. CMR is the gold standard for the assessment of CO. Special expensive equip‐
ment, trained personnel, sedation, and transportation of a neonate are needed to perform CMR. 
In adults, CMR is used to assess the function of the ventricles, in complex congenital heart 
disease and cardiomyopathy. Compared with adults, it is necessary to increase the image reso‐
lution in neonates, both spatially (because of the size of the heart), as well as the time (due to 
the relatively high heart rate of newborn). The essential advantages of this method are detailed 
assessment of CO, cardiovascular anatomy, and good repeatability. CMR cannot measure the 
oxygen need and consumption [26]. Images obtained by CMR in real time have lower quality. 
Kino CMR enables improved anatomy imaging and the ventricular wall motion, by which the 
heart is imaged at specific phases of the cardiac cycle, depending on the electrocardiographic 
(ECG) recording. This creates a series of images that can be played as a movie (kino). End‐dia‐
stolic and end‐systolic endocardial and epicardial borders are followed and we reconstruct 
three‐dimensional models of ventricles: end‐systolic and end‐diastolic volume, ejection frac‐
tion, and SV. CMR with a phase contrast allows the measurement of blood flow to the heart 
throughout the cardiac cycle [27]. This method quantifies the flow in IVC and descendent aorta, 
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which indicates the systemic perfusion in the premature neonate. Similarly, we can measure 
the flow in the internal carotid and basilar arteries and thus the blood flow in the brain [28].
Electrical impedance cardiometry is the only available method that enables continuous nonin‐
vasive monitoring of SV and CO in a neonate [29, 30]. The method is based on a model of the 
electrical velocimetry, using four‐surface ECG electrodes attached to the left side of the neck 
(two electrodes), and to the chest (two electrodes). Alternating electric current (AC) of constant 
amplitude flows through the pair of external electrodes toward the direction of the aorta. The 
ratio of the current and measured voltage is equal to the conductivity (or bioimpedance). Each 
tissue in the chest has its bioimpedance: that of the blood is very low, whole bone and lungs, 
filled with air, have high bioimpedance. Moreover, bioimpedance of bone is static, and bio‐
impedance of the lungs, which are filled and emptied of air, and of the heart and large blood 
vessels, which are filled with blood, is dynamic, in accordance with the respiratory or cardiac 
cycle. In case of sudden acceleration of blood flow into the aorta in systole, the conductivity dra‐
matically increases. Electrical bioimpedance of the chest is strongly increased with every heart‐
beat. The neonate’s movement causes artifacts in measuring the electrical impedance [31, 32].
Arterial pulse waveform analysis is a relatively good method for monitoring the dynamics of 
arterial blood pressure and assessment of CO. It is based on the analysis of the curve of arte‐
rial pulse waveform derived from arterial catheter and on the fact that the pulse pressure is 
proportional to SV [33]. The arterial pulse waveform changes in the case of arrhythmia, shock, 
or hypothermia, when it comes to peripheral vasoconstriction. Typically, the devices for cal‐
culating the SV and CO are based on the analysis of arterial pulse waveform, and require peri‐
odic, and in advance calibrations. An additional limitation of the method is that it assumes a 
constant rate of systemic vascular resistance [34]. So far, the methods of arterial pulse wave 
analysis have not been studied in neonates.
Invasive methods for assessing the CO have been developed in adults, and then applied 
in sick neonates, where their use is limited. Limitations of these methods are the invasive‐
ness, complexity, and relatively long process (need for central vascular approach and taking 
sequential blood samples for laboratory analysis), for which reason they are seldom used in 
practice. Invasive methods for estimating average CO over time are based on a few physical 
principles. Fick’s law is the law of mass/mass flow conservation. The amount of oxygen in 
the pulmonary artery and the amount of oxygen in the capillaries, flowing from the alveoli, is 
equal to the concentration of oxygen in the pulmonary vein [35].
Clinically, the O
2
 consumption can be measured by measuring the concentration of oxygen 
in the inhaled and exhaled air and pulmonary ventilation. Consumption is estimated as the 
difference between the amount of oxygen in the inhaled and exhaled air. The concentration of 
oxygen in the peripheral arteries is the same as in the pulmonary veins. Pulmonary arteries 
have mixed venous blood. Samples for the analysis of O
2
 are obtained from the pulmonary 
artery or the right ventricle through the cardiac catheter. Thus, we can calculate the CO (CO 
= O
2
 consumption/AVΔO
2
). Neonates compensate the reduced release of oxygen from fetal 
hemoglobin in tissues with higher hemoglobin concentrations, a larger volume of blood per 
unit of body weight, and increased CO. Instead of measuring O
2
 consumption, we can measure 
the formation of CO
2
 using capnography and assume that it is equal to the exchange of CO
2
 in 
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the lungs [36]. In neonates with a healthy alveolar‐capillary membrane, the partial pressure of 
CO
2
 in arterial blood is equal to the partial concentration of CO
2
 in the exhaled air [37].
Stewart principle is a method of dilution of the indicator and provides calculation of the CO 
on the basis of change in the concentration of the dye (lithium‐based dilution devices) or a 
change in the temperature of the solution (thermodilution‐based devices). We inject a known 
amount/temperature of a substance proximally and measure its concentration/temperature 
distally. We calculate the total flow rate (Q = m/∫cdt) from the time profile (integral) curve 
and a known quantity of the injected substance [38]. Clinically, a known amount of dye or 
isotope is injected rapidly into a large central vein, or the right side of the heart. We measure 
the concentration of dye or isotope in arterial blood: the larger the CO the greater the dilu‐
tion. The most common indicator is a small volume of cold saline; we calculate flow from the 
temperature change. The average blood flow through an organ can also be calculated from the 
change in the volume of the hollow body in time: dV/dt (volume of a cavity is imaged within 
a specified time sequence: by ultrasound, magnetic resonance, X‐ray).
4.3. Arterial blood pressure
Arterial blood pressure in the newborn can be measured noninvasively using appropriate cuffs 
or through the invasive arterial catheters. In principle, the matching of both methods is good 
[39]. We currently do not know what the normal arterial blood pressure is for a given gestational 
and postnatal age. Also, we do not know what the value of blood pressure is when the blood 
flow to vital organs is diminished and the auto‐regulatory mechanisms in the brain fail. Thus, 
neonatal hypotension is not precisely defined. In addition, there is currently no evidence that 
the treatment of hypotension has significant impact on the clinical outcome in neonates [40–42].
Global perfusion pressure is measured via invasive arterial blood pressure monitoring. 
However, “adequate” blood pressure does not signify an “adequate” CO; therefore, an increase 
in blood pressure does not necessary mean an increment of CO. However, without measuring 
CO we can only assume that adequate mean blood pressure means also adequate CO, which 
is not always true. Second, the increase in blood pressure does not always mean the elevation 
of CO (failing myocardium poorly responds to a high vascular resistance). In neonates, the 
threshold heart rates and perfusion pressure are different depending on gestational and post‐
menstrual age of premature neonates [42, 43].
5. The peripheral hemodynamic monitoring
Hemodynamic failure results in low cardiac output syndrome with inadequacy of oxygen 
and nutrients delivered to peripheral tissues and cells. Clinically, peripheral perfusion of 
organs can be assessed by observing the skin color of a neonate. The method is vastly sub‐
jective. A laboratory method of defining the peripheral perfusion is the measurement of the 
concentration of lactic acid in the peripheral blood. In case of lowered peripheral perfusion 
tissue hypoxia occurs, which leads to anaerobic metabolism and lactic acid formation. Lactic 
acid is present in the less perfused tissues and therefore it is primarily not present centrally 
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in systemic circulation; therefore, lactic acidosis (>2.5 mmol/L) is a late sign of low cardiac 
output syndrome. Consequently, the concentration of lactic acid in the systemic blood rises 
after the reanimation. Moreover, the production of lactic acid is increased in the case of 
adrenaline treatment, which increases glycogenolysis and glycolysis in the liver [44]. The 
plasma concentration of the lactic acid is associated with the stage of the disease and a higher 
mortality in neonates [45].
Noninvasively, the peripheral perfusion may be assessed by the perfusion index [46]. It is 
based on an analysis of the pulse oximetry signal. The perfusion index is the ratio between pul‐
satile and non‐pulsatile pulse oximetry signal (AC/DC × 100). It reflects the difference between 
the amount of blood in the tissue between systole and diastole. The perfusion index correlates 
well with the capillary refill time, the surface‐core body temperature difference [47], and also 
the severity of the disease in neonates [48].
Assessing the function of peripheral organs is another way of assessing the peripheral hemo‐
dynamics. Using amplitude‐integrated electroencephalogram (aEEG), we assess the brain 
function. Observing respiratory rate and pattern indicates the lung function and myocardial 
contractility indicates the heart function. By measuring the urine output and cleared sub‐
stances, we assess the renal function. Measurement of diuresis in the neonate for hemody‐
namic monitoring has many caveats, especially in premature neonates, since immature renal 
tubules are not able to concentrate the urine. Moreover, the accurate monitoring of diure‐
sis is an invasive method. Laboratory measurements of liver enzymes, clotting factors, and 
ammonia concentration assess liver function, and measurements of muscle enzyme assess the 
muscle function [49].
The peripheral monitors enable measuring the micro‐vascular blood flow to the periph‐
eral organs by perfusion index and laser‐Doppler method and regional tissue oxygenation 
by NIRS.
5.1. The regional blood flow monitoring in the peripheral organs in the neonate
Regional blood flow is a complex and dynamic variable that changes depending on the func‐
tional activity of the body. In pathological conditions, like, for example, a sudden change in 
blood pressure or hypoxia, blood flow through the body can change very quickly. Like CO 
also the regional blood flow is measured in mL/min and expressed either normalized by body 
weight either by 100 g of tissue, or as a percentage of the CO. Assessing and measuring the 
blood flow is not a part of the permanent clinical practice in neonatal intensive care units, 
because the methods are generally complicated, inaccurate, invasive, and expensive, and cur‐
rently their use is not showing clinical welfare for sick newborns.
With the help of the abovementioned physical principles and listed methods for CO monitor‐
ing, it is also possible to estimate the regional blood flow in peripheral organs. Using Fick’s 
law, we can calculate blood flow through the peripheral organ, knowing its oxygen con‐
sumption. By applying this principle, several methods for the evaluation of blood flow in the 
brain—through the inhalation of 15% nitrous oxide [50] and the clearance of a radioactive 
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isotope of xenon [51]—have been developed. Regional blood flow to peripheral organs can be 
measured using Doppler ultrasound [52]. The method is based on measuring the blood flow 
velocity through the blood vessel. The product of the flow rate and maximum vessel diam‐
eter allows us to evaluate blood flow in the vessel, and if the vessel supplies the oxygen and 
nutrients to the organ we can estimate the blood flow to the organ. Blood flow to the brain 
can also be measured using magnetic resonance imaging (MRI) techniques. Blood flow to the 
brain is supplied by four arteries in the neck; hence, it can be evaluated using a scan through 
the arteries: the cross section of the vessels is multiplied by the blood flow velocity. The blood 
flow velocity is measured by the loss of magnetization caused by the fresh blood flowing into 
the plane of imaging (imaging with phase contrast) [28]. For quantitative measurement of the 
flow, a contrast agent containing gadolinium can be used [53]. The blood flow in each blood 
vessel can be measured with an electromagnetic flowmeter: the moving particles‐ions are 
deflected to right angles to the direction of movement in an electric field and by that deflec‐
tion the electric current is measured. Blood flow can also be measured by thermodilution 
method: the faster the blood flow, the cooler the tip of the heated sensor. Using the plethys‐
mography, the displaced blood volume from the vessels is measured [38].
Frequently used noninvasive and continuous method for the indirect assessment of blood 
flow in various organs is the spectroscopy in the near‐infrared spectrum [54–56]. The method 
is based on the principle of different absorption patterns of oxyhemoglobin and deoxyhemo‐
globin. It measures the index of tissue oxygenation and enables the calculation of the extrac‐
tion of oxygen of the tissues in the target organ. If we assume that changes in the regional 
tissue oxygenation are not accompanied by changes in the arterial blood oxygen saturation 
(SaO
2
), oxygen consumption, the amount of blood in the arteries and veins, and hemoglobin 
concentration, then the measured tissue oxygenation can be used to assess organ perfusion. 
NIRS optodes can be placed practically anywhere on the surface of the body, they measure 
tissue oxygenation approximately 4 cm below the surface (in the brain, kidneys, intestines, 
liver, and muscle) [57].
5.2. Microcirculation monitoring in the neonate
Microcirculation encompasses arterioles, capillaries, arteriolar‐venous connections, venules, 
and lymphatic vessels. It supplies the target organs with oxygen and nutrients. Capillary fill‐
ing or opening depends on the tone of arterioles and precapillary sphincters, whose diameter 
changes in parallel to the contractions/relaxations of smooth muscle in the vessel wall. The 
humoral factors, endothelial vasodilators (NO, CO, and H
2
S), vasoconstrictors (epinephrine, 
norepinephrine, and endothelin‐1), myogenic mechanism, local metabolites, and the para‐
sympathetic nervous system affect the tone of smooth muscles. Blood flow in the microcircu‐
lation reflects the function of the central elements of the blood flow and is thus the ultimate 
indicator of cardiovascular efficiency. Microcirculation in individual organs also operates 
globally and represents one of the largest virtual organs in the body. In adults, it is estimated 
that 5% of the total blood volume is located in the capillaries, which may increase its capacity 
to fourfold [58].
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Microcirculation in the newborn can be assessed using a variety of methods, the most 
commonly used is the evaluation of flow by laser‐Doppler method, video microscopy 
(dynamic capillaroscopy), and xenon clearance techniques [59]. Flow measurement by 
laser‐Doppler method is based on the fact that the frequency of the light beam, which 
passes through the tissue, changes as a result of reflection from the moving parts—red 
blood cells (the Doppler effect). The flow is proportional to the concentration and speed 
of moving red blood cells in the microcirculation. Since the flow in microcirculation is 
highly variable, we usually assess microcirculatory response to some of the challenge 
tests and monitor the dynamics of change. The most commonly used provocation meth‐
ods are the postocclusive reactive hyperemia (hyperemia after a transitional cuffing of 
the proximal artery), thermal methods (local heating or cooling), and iontophoresis of 
vasoactive substances [60, 61]. In the first days after birth, the blood flow is very fragile 
and the peripheral blood flow in the microcirculation is unstable. The myogenic and 
nervous controls of skin blood flow enable thermoregulation. The blood flow to the skin 
in the first days after birth is reduced. The blood flow is related to gestational and post‐
natal age and the incidence of morbidity and cardiovascular function [62]. The deterio‐
ration of peripheral blood flow regulation in microcirculation causes vasodilation and 
decreased peripheral vascular resistance and contributes to the vulnerability of blood 
flow. The peripheral blood flow in the first days after birth differs in boys and girls; 
boys have stronger vasodilation; the mechanism is possibly associated with an increased 
incidence of hypotension in newborn males [63].
6. Limitations
The described methods for hemodynamic monitoring of neonates have many limitations. The 
clinical ones are vastly subjective and do not correlate well with the laboratory methods. The 
continuous bedside noninvasive methods are less accurate and sometimes demand complex 
deducement to what is happening. There are no trials on resuscitation using the noninva‐
sive methods. The more sophisticated noninvasive methods require expensive equipment 
and are time consuming, measuring the parameters in the moment of measurement and not 
continuously.
7. Conclusion
Hemodynamic monitoring, which was for a long time not available in neonates and prema‐
tures, is becoming an indispensable tool for understanding how cardiovascular system adapts 
to extrauterine life. This is especially important when treating the smallest premature with 
peculiar and very vulnerable hemodynamics. This article adds some of the latest information 
on hemodynamic monitoring in neonates with specific emphasis on the methods which are 
available, cost‐effective, noninvasive, and easy to manage and understand.
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